Plasma kallistatin levels in patients with severe community-acquired pneumonia

INTRODUCTION: Community-acquired pneumonia (CAP) requiring intensive care unit (ICU) treatment commonly causes acute respiratory failure with high mortality. Kallistatin, an endogenous tissue kallikrein inhibitor, has been reported to be protective in various human diseases. The aim of this study wa...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Lin, Wei-Chieh, Lu, Shiou-Ling, Lin, Chiou-Feng, Chen, Chang-Wen, Chao, Lee, Chao, Julie, Lin, Yee-Shin
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2013
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4056893/
https://ncbi.nlm.nih.gov/pubmed/23394256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc12507
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia